Dr. Menna Ahmed

@menna please shorten and sharpen if possible

• Led over 7 projects contributing to timely project delivery in a GxP environment.
• Designed, developed, validated, and optimized qPCR and ddPCR assays including multiplex platforms in accordance with regulatory standards.
• Provided scientific leadership, mentoring lab associates and coordinating cross-functional teams across German and US sites.
• Acted as Study Lead and Subject Matter Expert (SME), including successful participation in client bid defenses.
• Contributed to strategic planning for portfolio expansion and innovation in assay technologies.
• Authored SOPs, coordinated interdepartmental alignment, and supported BD initiatives and proposal development.
• Established digital PCR platforms and wrote tech transfer proposals that resulted in the signing of two lucrative contracts.
• Regularly interfaced with clients, providing project updates and influencing scientific decision-making.
• Utilized Linux command-line tools for data processing, automation, and report generation.

• Developed a live cell imaging-based HTS assay for FGF2 inhibitors for cancer therapy, leading to a patent application (PCT/EP2015/073591) and first-author publication.
• Designed and implemented a screening strategy for 19,000 compounds and validated hits using in vitro assays.
• Initiated and led collaboration with computational biologists to streamline data analysis and reduce project timelines.
• Presented work at EMBL and trained peers on live-cell imaging platforms and assay workflows.
• Co-supervised undergraduate students, fostering scientific curiosity and technical development.

• Contributed to development of a Selected Reaction Monitoring (SRM) MS peptide library for the yeast proteome.
• Analyzed cellular stress response related to protein aggregation, resulting in a conference poster.
• @menna add numbers if you can